Richardson Linda M
Insider CIK 1595064 · CMRX Chief Commerical Officer · ICPT EVP & Chief Commercial Officer · ALT Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALT Altimmune, Inc. | M Exercise deriv | 2026-09-16 | 2026-09-17 | 24,000 | — | $0 | 72,000 | SEC↗ |
| ALT Altimmune, Inc. | M Exercise | 2026-09-16 | 2026-09-17 | 24,000 | — | $0 | 24,000 | SEC↗ |
| ALT Altimmune, Inc. | F Tax w/h | 2026-09-16 | 2026-09-17 | 6,826 | $3.24 | $22.1K | 17,174 | SEC↗ |
| ALT Altimmune, Inc. | M Exercise deriv | 2026-09-16 | 2026-09-17 | 24,000 | — | $0 | 72,000 | SEC↗ |
| ALT Altimmune, Inc. | F Tax w/h | 2026-09-16 | 2026-09-17 | 6,826 | $3.24 | $22.1K | 17,174 | SEC↗ |
| ALT Altimmune, Inc. | M Exercise | 2026-09-16 | 2026-09-17 | 24,000 | — | $0 | 24,000 | SEC↗ |
| ALT Altimmune, Inc. | A Award deriv | 2025-09-16 | 2025-09-17 | 96,000 | — | $0 | 96,000 | SEC↗ |
| ALT Altimmune, Inc. | A Award deriv | 2025-09-16 | 2025-09-17 | 278,000 | — | $0 | 278,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 8,368 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 9,500 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 5,896 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 5,000 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 8,500 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 3,912 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 20,000 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 17,600 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | U Tender | 2023-11-08 | 2023-11-13 | 16,706 | $19.00 | $317.4K | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer | 2023-11-08 | 2023-11-13 | 26,585 | $19.00 | $505.1K | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2023-02-14 | 2023-02-16 | 386 | $21.21 | $8.2K | 43,291 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2023-01-27 | 2023-01-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2023-01-27 | 2023-01-31 | 12,200 | — | $0 | 43,677 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2022-12-31 | 2023-01-03 | 1,600 | $12.37 | $19.8K | 31,477 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2022-09-01 | 2022-09-06 | 597 | $18.06 | $10.8K | 33,077 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2022-08-15 | 2022-08-17 | 124 | $18.19 | $2.3K | 33,674 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2022-05-15 | 2022-05-17 | 124 | $17.88 | $2.2K | 33,798 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2022-02-15 | 2022-02-17 | 171 | $15.93 | $2.7K | 33,922 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2022-02-14 | 2022-02-15 | 529 | $14.85 | $7.9K | 34,093 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2022-01-27 | 2022-01-31 | 17,600 | — | $0 | 17,600 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2022-01-27 | 2022-01-31 | 10,300 | — | $0 | 34,622 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2021-12-31 | 2022-01-04 | 1,211 | $16.29 | $19.7K | 24,322 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2021-11-15 | 2021-11-17 | 171 | $17.67 | $3.0K | 25,533 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2021-09-01 | 2021-09-03 | 820 | $15.05 | $12.3K | 25,704 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2021-08-15 | 2021-08-16 | 171 | $14.92 | $2.6K | 26,524 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2021-05-15 | 2021-05-17 | 171 | $18.15 | $3.1K | 26,695 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2021-02-15 | 2021-02-17 | 8,500 | — | $0 | 8,500 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2021-02-15 | 2021-02-17 | 5,531 | — | $0 | 26,866 | SEC↗ |
| CMRX CHIMERIX INC | F Tax w/h | 2018-05-14 | 2018-05-15 | 4,545 | $4.66 | $21.2K | 54,161 | SEC↗ |
| CMRX CHIMERIX INC | F Tax w/h | 2018-02-02 | 2018-02-05 | 2,290 | $4.67 | $10.7K | 58,706 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2018-01-25 | 2018-01-29 | 135,000 | — | $0 | 135,000 | SEC↗ |
| CMRX CHIMERIX INC | S Sale | 2017-12-01 | 2017-12-05 | 19,833 | $4.47 | $88.7K | 60,996 | SEC↗ |
| CMRX CHIMERIX INC | F Tax w/h | 2017-05-12 | 2017-05-16 | 10,167 | $4.68 | $47.6K | 80,829 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2017-01-24 | 2017-01-26 | 60,750 | — | $0 | 60,750 | SEC↗ |
| CMRX CHIMERIX INC | A Award | 2017-01-24 | 2017-01-26 | 30,375 | — | $0 | 90,996 | SEC↗ |
| CMRX CHIMERIX INC | A Award | 2016-05-09 | 2016-05-11 | 60,000 | — | $0 | 60,621 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2016-01-08 | 2016-01-12 | 178,000 | — | $0 | 178,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2015-01-28 | 2015-01-30 | 65,000 | — | $0 | 65,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2014-01-08 | 2014-01-09 | 120,000 | — | $0 | 120,000 | SEC↗ |